The Big Biz Show: November 2024
In this episode of the Big Biz Show, our CEO, Christian Kanstrup, shares the intriguing story of Evaxion and how the company, rooted in machine learning and advanced computational methods, emerged as one of the very few AI-first companies. Since the inception in 2008, Evaxion have developed a unique and strongly validated AI-Immunology™ platform that, as Christian explains it, positions us at the forefront of using AI to discover, design, and develop novel vaccine candidates for cancer and infectious diseases.
In the latter part of the interview, you will also hear more about our leading personalized peptide-based cancer vaccine, EVX-01, and how we target the unique tumor profile and immune characteristics of each patient with metastatic melanoma.
By The Big Biz Show
